ArticleMethods in molecular biology (Clifton, N.J.)2027
Identification of Domain Formation During sPLA2 Activity by Biophotonics.
Article in Methods in molecular biology (Clifton, N.J.), 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aim of this study was to identify the formation of membrane domains during the interfacial activation of pancreatic sPLA2 using fluorescence spectroscopy. The identification of phospholipase A2 (PLA2) activity by biphotonic methods is based on the behavior of fluorescent molecules present in the liposomal systems (enzyme-substrate). The liposomal system consists of a lipid membrane, which can be anything from a liposome to a cell membrane, and the PLA2 enzyme. Liposomes are biophysical models that can be used to study physicochemical processes, which boost the catalytic reaction at the heterogeneous interface between the aqueous phase (enzyme localization) and the lipid phase (substrate localization), for example, the study of membrane remodeling generated by the reaction products of PLA2. The PLA2 superfamily comprises a wide variety of enzymes that promote the hydrolysis of the sn-2 ester bond of phosphoglycerides. This enzyme is found in active form mainly in the pancreas but is distributed throughout the body in different organs and has been found to act during the effects of various chronic pathologies associated with some inflammatory responses. One of the fluorescent molecules used to identify the PLA2 catalysis reaction is C12-NBD-FA. The same molecule is also used as a monitor to detect the formation of domains during PLA2 activity, through the principle of the Forster resonance energy transfer (FRET) method, where a fluorescent acceptor molecule and a fluorescent donor molecule are chosen to measure the changes in fluorescence intensity in the system before and after the catalytic reaction. For this protocol, the fluorescent molecule octadecyl rhodamine chloride (C18-Rho) was chosen as the fluorescence acceptor and C12-NBD-FA as the donor to form the FRET pair. This protocol was performed on DPPC liposomes in gel or liquid crystalline state, and the changes in fluorescence were detected as a function of time at the donor emission length. The reversal in fluorescence that occurred while triggering the secretory PLA2 (sPLA2) activity was interpreted based on the change in transfer efficiency.
Indexed as
Identifiers
42778863What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.